Enhancing affinity of neutralizing SARS-CoV-2 nanobody through facile structure-guided mutations in CDRs
V. Singh, M. Bhutkar, S. Choudhary, S. Nehul, R. Kumar, J. Singla, P. Kumar, S. Tomar
This study enhances the affinity of SARS-CoV-2 neutralizing nanobodies through structure-guided mutations in CDRs, resulting in improved neutralization activity against pseudovirus.
bioRxiv · May 13, 2024 · PreprintBioengineering